Research AppraisalSystematic Review

Global trends in travel-related antimicrobial resistance: a systematic review, 2020-2024

International healthTetteh-Ocloo, Georgina, Odoom, Alex, Dayie, Nicholas T K D et al.8 May 2026DOI

Clinical Snapshot

70CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationInternational travellers with antimicrobial resistant bacterial infections
I — InterventionInternational travel exposure
C — ComparatorNot explicitly defined (temporal trends analysis)
O — OutcomesPrevalence, diversity, and geographic patterns of travel-associated antimicrobial resistance

Bottom Line

This systematic review of 10 studies involving 359 antimicrobial-resistant isolates demonstrates a concerning upward trend in travel-associated AMR from 2020-2024. The 15.3% prevalence of multidrug-resistant strains by 2024, particularly ESBL-producing E. coli and colistin-resistant Enterobacterales from Southeast Asia and Africa, has direct implications for Australian clinical practice. Healthcare exposure during travel emerged as a significant risk factor. While the small sample size limits the strength of evidence, the consistent temporal trends support enhanced pre-travel counselling, antimicrobial stewardship, and post-travel screening protocols. Australian clinicians should maintain high suspicion for resistant pathogens in returning travellers, particularly from identified high-risk regions, and consider empirical therapy adjustments based on travel history and regional resistance patterns.

Evidence: Moderate

Key Findings

  • P Value: Not reported

  • Effect Size: 15.3% multidrug-resistant strains by 2024

  • Primary Outcome: Consistent rise in travel-associated antimicrobial resistance from 2020-2024

  • Nnt Or Sensitivity: Southeast Asia and Africa identified as major source regions for resistant pathogens

  • Confidence Interval: Not reported

Clinical Application

Findings support existing travel medicine recommendations for antimicrobial stewardship and infection prevention Highly relevant given Australia's proximity to Southeast Asia; supports TGA antimicrobial resistance strategy and RACGP travel medicine guidelines for pre-travel counselling and post-travel screening Australian travellers, particularly those visiting Southeast Asia and Africa or requiring healthcare abroad

Abstract

Antimicrobial resistance (AMR) is a growing global health threat, with international travel playing a key role in the spread of resistant bacteria. This systematic review examines trends in travel-associated AMR from 2020 to 2024. A search of PubMed, Scopus and Web of Science identified 10 studies involving 359 AMR isolates. Using the Newcastle-Ottawa scale, the study quality was assessed and findings were synthesised to identify patterns in prevalence, diversity and geographic spread. Results revealed a consistent rise in travel-associated AMR, particularly from regions such as Southeast Asia and Africa, which acted as major sources of diverse resistant pathogens. These include extended spectrum beta-lactamase-producing Escherichia coli, multidrug-resistant (MDR) Corynebacterium diphtheriae and colistin-resistant Enterobacterales. The number of MDR strains increased over time, making up 15.3% of cases by 2024. Healthcare exposure during travel emerged as a significant risk factor. Overall, the prevalence and diversity of AMR bacteria linked to travel have risen steadily, highlighting the urgent need for global cooperation. Enhanced surveillance, antimicrobial stewardship, infection control measures and international collaboration are essential to curb the spread of these dangerous pathogens.

References

  1. 1.Tetteh-Ocloo, G., Odoom, A., Dayie, N. T. K. D., & Donkor, E. S. (2026). Global trends in travel-related antimicrobial resistance: a systematic review, 2020-2024. International Health. https://doi.org/10.1093/inthealth/ihaf071
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service